Literature DB >> 17351228

Hypokalaemia and sudden cardiac death--lessons from implantable cardioverter defibrillators.

Micha Maeder1, Hans Rickli, Christian Sticherling, Regula Widmer, Peter Ammann.   

Abstract

The cases of four patients experiencing ventricular arrhythmia secondary to drug-induced hypokalaemia requiring treatment by a previously implanted cardioverter defibrillator (ICD) are reported here. In three cases, hypokalaemia developed within a short period of time after modification of diuretic regimen with loop and thiazide diuretics had been carried out or potassium-sparing drugs had been withdrawn. In one patient, hypokalaemia occurred after months of treatment with several potassium-sparing and non-potassium-sparing diuretics. The fact that the combination of thiazide and loop diuretics can be associated with pronounced hypokalaemia and life-threatening arrhythmias, which may be terminated by device treatment in patients with an ICD but may be fatal in patients with structural heart disease but without an ICD, is highlighted here. Prompt recognition and correction of hypokalaemia is mandatory if such patients present to the emergency department.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17351228      PMCID: PMC2660031          DOI: 10.1136/emj.2006.044073

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  9 in total

1.  Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study.

Authors:  Morten Svensson; Finn Gustafsson; Søren Galatius; Per R Hildebrandt; Dan Atar
Journal:  BMJ       Date:  2003-11-15

Review 2.  Diuretic therapy.

Authors:  D C Brater
Journal:  N Engl J Med       Date:  1998-08-06       Impact factor: 91.245

Review 3.  Hypokalemia.

Authors:  F J Gennari
Journal:  N Engl J Med       Date:  1998-08-13       Impact factor: 91.245

4.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

5.  Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction.

Authors:  H A Cooper; D L Dries; C E Davis; Y L Shen; M J Domanski
Journal:  Circulation       Date:  1999-09-21       Impact factor: 29.690

6.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

7.  Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.

Authors:  David N Juurlink; Muhammad M Mamdani; Douglas S Lee; Alexander Kopp; Peter C Austin; Andreas Laupacis; Donald A Redelmeier
Journal:  N Engl J Med       Date:  2004-08-05       Impact factor: 91.245

8.  Diuretic therapy for hypertension and the risk of primary cardiac arrest.

Authors:  D S Siscovick; T E Raghunathan; B M Psaty; T D Koepsell; K G Wicklund; X Lin; L Cobb; P M Rautaharju; M K Copass; E H Wagner
Journal:  N Engl J Med       Date:  1994-06-30       Impact factor: 91.245

Review 9.  What is the optimal serum potassium level in cardiovascular patients?

Authors:  John E Macdonald; Allan D Struthers
Journal:  J Am Coll Cardiol       Date:  2004-01-21       Impact factor: 24.094

  9 in total
  1 in total

1.  Furosemide and Potassium Chloride-induced Alteration in Protein Profile of Left Ventricle and its Associated Risk for Sudden Cardiac Death.

Authors:  Ponniah Senthil Murugan; Govindan Sadasivam Selvam
Journal:  Toxicol Int       Date:  2014-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.